ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일
데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.
US label: colorectal, non-squamous NSCLC, glioblastoma, renal, cervical and ovarian cancers; regimen-specific indicatio… · VEGF-A
HER2+ breast cancer, HER2+ gastric/GEJ adenocarcinoma · HER2
US label: head and neck squamous cell cancer and biomarker-selected colorectal cancer; regimen-specific indications · EGFR
HER2-positive breast cancer (including regimen-specific first-line and early-stage indications); HER2-low/ultralow brea… · HER2
TNBC: regimen-specific first-line and previously treated indications; HR-positive/HER2-negative breast cancer after spe… · TROP2
HER2+ breast cancer · HER2
HR-positive/HER2-negative breast cancer after specified prior therapies; EGFR-mutated NSCLC after specified prior thera… · TROP2
Extensive-stage small cell lung cancer after platinum-based chemotherapy · DLL3 × CD3
First-line HER2-positive gastric, GEJ, or esophageal adenocarcinoma; previously treated HER2-positive biliary tract can… · HER2 (biparatopic)
FRα-positive platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer · FRα (folate receptor alpha)
High-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) · IFNα2b (adenoviral)
Colorectal Cancer · HER2
Hepatocellular Carcinoma · Muscle Invasive Bladder Cancer
Breast Cancer · Breast Cancer
Non-small Cell Lung Cancer · Leptomeningeal Metastasis
Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Non-Small Cell Lung Cancer Metastatic
Metastatic Colorectal Cancer; Liver Metastases · Gastric Cancer
Triple-Negative Breast Cancer · Colorectal Cancer
Platinum Resistant Ovarian Cancer; Platinum Refractory Epithelial Ovarian Cancer · Gastric Cancer (GC)
1 / 34 pages
자동 수집 갱신 권장 · 9월 2일 · 방문 0 / 0